Transcatheter Tricuspid Valve Repair for Right Heart Failure Transcatheter Tricuspid Valve Repair for Right Heart Failure
Tricuspid valve regurgitation has long been understudied and undertreated, but new studies are advancing our understanding of transcatheter tricuspid valve edge-to-edge repair for right-sided HF.JACC: Heart Failure (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - August 21, 2020 Category: Surgery Tags: Cardiology Journal Article Source Type: news

What Is Transcatheter Aortic Valve Replacement (TAVR)?
Title: What Is Transcatheter Aortic Valve Replacement (TAVR)?Category: Procedures and TestsCreated: 7/29/2020 12:00:00 AMLast Editorial Review: 7/29/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - July 29, 2020 Category: Cardiology Source Type: news

Engineers find thinner tissues in replacement heart valves create problematic flutter
(Iowa State University) Iowa State and University of Texas engineers have developed high-fidelity computational models of replacement heart valves to examine the performance of biological tissues built into the valves. They found that thinner tissues can flap and flutter, which can damage the valves and even the blood that flows by. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 29, 2020 Category: International Medicine & Public Health Source Type: news

Edwards' KONECT RESILIA Aortic Valved Conduit Receives FDA Approval For Complex Aortic Valve Surgeries
IRVINE, Calif., July 15, 2020 -- (Healthcare Sales & Marketing Network) -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received... Devices, Cardiology, Surgery, FDA Edwards Lifesciences, KONECT RESILIA, aortic valved conduit (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 15, 2020 Category: Pharmaceuticals Source Type: news

Coronavirus Shows the Dangers of Letting Market Forces Govern Health and Social Care
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post Coronavirus Shows the Dangers of Letting Market Forces Govern Health and Social Care appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - July 15, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health Source Type: news

New heart valve could transform open heart surgery for millions of patients globally
A new polymeric heart valve with a life span potentially longer than current artificial valves that would also prevent the need for the millions of patients with diseased heart valves to require life-long blood thinning tablets has been developed by scientists at the universities of Bristol and Cambridge. The team's latest in-vitro results, published in Biomaterials Science, suggest that the PoliValve could last for up to 25 years. (Source: University of Bristol news)
Source: University of Bristol news - June 29, 2020 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Translational Health Sciences, Institutes, Institutes, Bristol Heart Institute; Press Release Source Type: news

SAVR Following TAVR May Present Extra Risks SAVR Following TAVR May Present Extra Risks
Patients undergoing surgical aortic-valve replacement following problems with an initial transcatheter aortic-valve replacement appear to have particularly poor outcomes, according to a retrospective analysis.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 19, 2020 Category: Surgery Tags: Cardiology News Source Type: news

4D Flow MRI is feasible during exercise
Cardiac 4D flow MRI can quantify blood flow in the ascending aorta and main...Read more on AuntMinnie.comRelated Reading: AI speeds up reconstruction of 4D flow MRI MRI finds gender differences even in healthy hearts Advances in imaging, AI make cardiac MRI more accessible 4D flow MRI, 3D printing improve congenital heart surgery Heart valve-tracking algorithm boosts viability of 4D MRI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 19, 2020 Category: Radiology Source Type: news

Cardiologist investigates why TAVR might not work for some heart patient
(University of Cincinnati) A University of Cincinnati physician-researcher hopes a better understanding of how platelets function might help determine why some patients aren't good candidates for a transcatheter aortic valve replacement. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 3, 2020 Category: International Medicine & Public Health Source Type: news

PET/MRI shows inflammation link to mitral valve prolapse
Researchers using a hybrid PET/MRI scanner detected a link between degenerative...Read more on AuntMinnie.comRelated Reading: 4 core applications of cardiovascular 3D printing Cardiac ultrasound at bedside boosts disease diagnosis ACC: Echocardiography identifies patients for valve repair Right heart quantification awareness: Part 6 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 1, 2020 Category: Radiology Source Type: news

Outcomes Similar After TAVR in Bicuspid, Tricuspid Anatomy
WEDNESDAY, May 27, 2020 -- All-cause mortality and stroke are comparable at 30 days and one year after transcatheter aortic valve replacement (TAVR) among patients with bicuspid and tricuspid valve stenosis, according to a study published online May... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 27, 2020 Category: Pharmaceuticals Source Type: news

Edwards PASCAL Transcatheter Valve Repair System Receives European Approval For Tricuspid Repair
IRVINE, Calif., May 18, 2020 -- (Healthcare Sales & Marketing Network) -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has ... Devices, Interventional, Cardiology, Regulatory Edwards Lifesciences, PASCAL transcatheter valve, tricuspid regurgitation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 18, 2020 Category: Pharmaceuticals Source Type: news

What Is a Percutaneous Valve Replacement Procedure?
Title: What Is a Percutaneous Valve Replacement Procedure?Category: Procedures and TestsCreated: 5/14/2020 12:00:00 AMLast Editorial Review: 5/14/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - May 14, 2020 Category: Cardiology Source Type: news

How Dangerous Is Percutaneous Heart Valve Replacement Surgery?
Title: How Dangerous Is Percutaneous Heart Valve Replacement Surgery?Category: Procedures and TestsCreated: 5/14/2020 12:00:00 AMLast Editorial Review: 5/14/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - May 14, 2020 Category: Cardiology Source Type: news

Best Practices for Human-Centric Design of Medical Devices
Medical devices designed to accommodate human variability present a growing opportunity for the healthcare and life sciences industries. Historically, medicine has solved many of the “simple” issues first: how to fix a broken leg has been known for centuries! But today we have treatments that didn’t even exist a generation ago, such as the use of stents and replacement valves for heart disease. These devices address a more limited cohort of people and are most successful when designed to be patient-specific. The cohorts themselves must also be further defined to account...
Source: MDDI - May 5, 2020 Category: Medical Devices Authors: Kristian Debus Tags: Design Source Type: news

CT helps predict TAVR outcomes
Identifying fibrotic lung disease on CT before transcathetor aortic valve replacement...Read more on AuntMinnie.comRelated Reading: 4D CT sheds light on post-TAVR treatment strategies 3D printing technique improves heart valve sizing 3D-printed aortas could work well for TAVR 3D printing helps evaluate leaks after TAVR procedures CT better than echo for aortic annulus before TAVR (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 4, 2020 Category: Radiology Source Type: news

Medtech in a Minute: Another Deal Bites the Dust, Telemedicine Changes the Game, and More
Another Deal Bites the Dust Citing a negative market impact from COVID-19, Alphatec backed out of its agreement to acquire EOS Imaging. While the deal is no longer feasible as contemplated, Alphatec said it is open to a strategic collaboration, if EOS is willing. Earlier this month, Organovo killed a proposed merger with Tarveda Therapeutics, but not because of the pandemic. That decision was prompted by indecisive scientific data on Organovo's part. Telemedicine Is Changing the Diabetes Game Telemedicine is emerging as the hero technology during COVID-19. In the diabetes space, the technology is enabling new patient acces...
Source: MDDI - April 30, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Edwards Lifesciences Drops 2020 Revenue Guidance Due to COVID-19
While Edwards Lifesciences reported first-quarter sales growth of 14%, the structural heart company saw a steep drop in procedure volume in the last few weeks of the quarter due to COVID-19. "As you might expect, procedure volumes in March varied greatly by geography, even by hospital, as patients and providers turned their focus to the pandemic," CEO Mike Mussallem said during the company's first-quarter earnings call, according to a SeekingAlpha transcript. Mussallem said the company expects the impact of COVID-19 on its transcatheter aortic valve replacement (TAVR) sales to be most severe in the second quarter...
Source: MDDI - April 25, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: COVID-19 Business Source Type: news

Catheter-Based Solution Being Developed to Treat Heart Valve Calcification
Pi-Cardia Ltd. has raised $27 million to develop a catheter-based solution to treat heart valve calcification. The Rehovot, Israel-based company said the financing was led by Sonfinnova Partners and joined by Professor Jacques Séguin, Chairman of the company, with further participation from existing investors. The financing follows the successful completion of the company’s First-In-Human studies of the Leaflex Catheter. Pi-Cardia said its technology performs mechanical scoring of valve calcification, restoring leafelts’ mobility and improving valve hemodynamics. The company...
Source: MDDI - April 20, 2020 Category: Medical Devices Authors: MDDI Staff Tags: Business Cardiovascular Source Type: news

PET/CT pinpoints Hodgkin's lymphoma treatment response
PET/CT significantly outperformed CT alone in predicting treatment response...Read more on AuntMinnie.comRelated Reading: FDG-PET leads prediction on neuroendocrine tumor outcomes IMV: PET scan volume continues growing at steady pace FDG-PET/CT points to cervical cancer patient outcomes FDG-PET/CT within a year of heart valve surgery looks safe PET/CT beats SPECT for neuroendocrine tumors (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 20, 2020 Category: Radiology Source Type: news

Low-Risk TAVR Loses Ground at 2 Years in PARTNER 3 Low-Risk TAVR Loses Ground at 2 Years in PARTNER 3
Transcatheter aortic valve replacement (TAVR) continued to show superiority over surgical replacement at 2 years'follow-up, but between-group differences narrowed considerably.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 16, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Abbott's TriClip(TM) Becomes First Device of its Kind to Receive CE Mark for Minimally Invasive Tricuspid Valve Repair
CE Mark for TriClip represents an important treatment option for people with severe tricuspid regurgitation, a difficult-to-manage heart condition New system offers a proven safe and effective minimally invasive non-surgical solution The TriClip Syst... Devices, Interventional, Cardiology, Regulatory Abbott, TriClip, Transcatheter, Tricuspid Valve Repair, Tricuspid Valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2020 Category: Pharmaceuticals Source Type: news

Abbott's TriClip ™ Becomes First Device of its Kind to Receive CE Mark for Minimally Invasive Tricuspid Valve Repair
- CE Mark for TriClip represents an important treatment option for people with severe tricuspid regurgitation, a difficult-to-manage heart condition (Source: Abbott.com)
Source: Abbott.com - April 9, 2020 Category: Pharmaceuticals Source Type: news

TAVR equivalent to surgery at 2 years among low-risk patients
(American College of Cardiology) Patients undergoing transcatheter aortic valve replacement (TAVR) fared equally well compared with those undergoing open heart valve replacement surgery in terms of the combined risk of death, stroke or rehospitalization at two years, the primary endpoint of the PARTNER 3 trial being presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 30, 2020 Category: International Medicine & Public Health Source Type: news

Antiplatelet drugs increase risk for TAVR patients with atrial fibrillation
(American College of Cardiology) Patients with atrial fibrillation who took oral anticoagulants alone after undergoing transcatheter aortic valve replacement (TAVR) had a lower rate of bleeding complications without an increased risk of clotting-related complications compared to patients who took antiplatelet medication in addition to oral anticoagulants, in a trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 30, 2020 Category: International Medicine & Public Health Source Type: news

TAVR shows favorable safety in patients with bicuspid valve
(American College of Cardiology) Transcatheter aortic valve replacement (TAVR) procedures had a high rate of success and low risk of death or disabling stroke at 30 days in patients with a bicuspid, or two-leaflet, aortic valve, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 30, 2020 Category: International Medicine & Public Health Source Type: news

Study finds room for improvement in TAVR outcomes across US
(American College of Cardiology) Thirty-four medical centers, representing 11% of facilities that perform transcatheter aortic valve replacement (TAVR) in the U.S., saw worse than expected outcomes in terms of survival and quality of life among patients undergoing the procedure in an analysis presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 30, 2020 Category: International Medicine & Public Health Source Type: news

TAVR found non-inferior to surgery in broad patient population
(American College of Cardiology) Patients who underwent transcatheter aortic valve replacement (TAVR) did not have a higher rate of death at one year compared with those who had their heart valve replaced via open-heart surgery, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 30, 2020 Category: International Medicine & Public Health Source Type: news

Landmark Phase 3 VOYAGER PAD Study of XARELTO ® (rivaroxaban) Plus Aspirin Shows Significant Benefit in Patients with Symptomatic Peripheral Artery Disease (PAD) after Lower-Extremity Revascularization
RARITAN, NJ, March 28, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin (100 mg once daily) was superior to aspirin alone in reducing the risk of major adverse limb and cardiovascular (CV) events by 15 percent in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization, with similar rates of TIMI[1] major bleeding. VOYAGER PAD is the only study to show a significant benefi...
Source: Johnson and Johnson - March 28, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session
RARITAN, N.J., March 20, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that it will unveil late-breaking data from its leading cardiovascular and metabolism portfolio during the virtual American College of Cardiology’s 69th Annual Scientific Session together with the World Congress of Cardiology (ACC.20/WCC) on March 28-30, 2020. Notably, four late-breaking abstracts for XARELTO® (rivaroxaban) will be presented, including data from the Phase 3 VOYAGER PAD study in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization.Click to...
Source: Johnson and Johnson - March 20, 2020 Category: Pharmaceuticals Source Type: news

Abbott Aims to Optimize TAVI Implants with European Approval of FlexNav(TM) Delivery System for the Company's Portico(TM) Valve
New FlexNav™ delivery system improves control and delivery of the Portico™ TAVI valve even in complex clinical cases The minimally invasive Portico procedure allows doctors to treat severe aortic valve stenosis without invasive surgery Approval of th... Devices, Interventional, Cardiology, Regulatory Abbott, FlexNav, Portico, transcatheter, aortic valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 5, 2020 Category: Pharmaceuticals Source Type: news

3D printing improves accuracy of knee arthroplasty
A new technique that relies on 3D-printed surgical guides designed with CT...Read more on AuntMinnie.comRelated Reading: Can ultrasound, 3D printing deepen maternal-fetal bonds? Can 3D printing help optimize cardiac CT protocols? 3D printing may improve safety of upper GI surgery 3D-printed head customizes neurosurgery simulation 3D printing technique improves heart valve sizing (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 3, 2020 Category: Radiology Source Type: news

Persistent Mitral Regurgitation After TAVR Bodes Ill in Some Persistent Mitral Regurgitation After TAVR Bodes Ill in Some
Patients with low-flow, low-gradient aortic stenosis (LFLG-AS) who don't show improvement in mitral regurgitation following transcatheter aortic-valve replacement (TAVR) face an increased risk of mortality, according to a substudy of a multicenter registry.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 26, 2020 Category: Radiology Tags: Cardiology News Source Type: news

Successful transcatheter mitral valve repair that enhances postoperative recovery
(Osaka University) Researchers at Osaka University succeed in Japan's first beating-heart surgery to repair a mitral valve without using artificial heart lung apparatus. This approach can avoid complications arising from the use of artificial heart lung apparatus, and more favorable and earlier postoperative recovery is expected. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 25, 2020 Category: International Medicine & Public Health Source Type: news

Cardiovalve Reaches 2 Milestones for its Tricuspid Valve Replacement System
Cardiovalve has a pair of milestones that could help catapult the company into the forefront of the tricuspid valve market. The Or Yehuda, Israel-based company received FDA approval for an early feasibility study of the transcatheter tricuspid valve replacement system and Breakthrough Device Designation for the technology. The study’s primary endpoint is the safety and feasibility of the Cardiovalve technology and procedure in reducing tricuspid regurgitation, with evaluations at 30 days and periodically up to five years. The study will be conducted in collaboration with five leading US hospitals. In a re...
Source: MDDI - February 21, 2020 Category: Medical Devices Authors: Omar Ford Tags: Regulatory and Compliance Cardiovascular Source Type: news

FDG-PET/CT points to cervical cancer patient outcomes
Several indicators on pretreatment FDG-PET/CT scans can help predict overall...Read more on AuntMinnie.comRelated Reading: Biomarkers on PET, MRI show breast cancer risk FDG-PET/CT within a year of heart valve surgery looks safe FDG-PET/CT helps predict tuberculosis relapse 2 new PET tracers may best FDG in cancer imaging FDG-PET/CT aids in melanoma treatment assessment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 13, 2020 Category: Radiology Source Type: news

Can 3D printing help optimize cardiac CT protocols?
Patient-specific 3D-printed coronary models have allowed clinicians to determine...Read more on AuntMinnie.comRelated Reading: 3 ways to advance 3D printing in radiology AR, 3D printing make waves in cardiac care 3D printing helps unravel rare cardiac anomalies 3D printing technique improves heart valve sizing 3D printing gives pediatric heart surgery a boost (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 7, 2020 Category: Radiology Source Type: news

Oregon man becomes first to receive minimally invasive heart valve repair
The tricuspid valve, on the right side of the heart between the top and bottom chambers, is very tricky to repair because of its complexity. Until recently, the only option was open-heart surgery. But an Oregon man recently became the first patient in a new clinical trial to have the valve repaired with a minimally invasive procedure. Dennis Eggers, a 73-year-old from Sweet Home, Oregon, said he’s feeling “very well,” about two months after his mid-December valve repair at Oregon Health… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 5, 2020 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news

Five-Year Outcomes Comparable for TAVR, Surgical AVR
TUESDAY, Feb. 4, 2020 -- There is no significant difference in the incidence of death or disabling stroke at five years among patients with aortic stenosis at intermediate surgical risk who undergo transcatheter aortic valve replacement (TAVR) or... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 4, 2020 Category: Pharmaceuticals Source Type: news

Abbott Wins Approval for CATALYST Trial for At-Risk Stroke Patients
This study is an extremely important step in assessing the Amplatzer Amulet as an effective non-prescription drug alternative for patients with AFib who are at an increased risk for ischemic stroke." In an email sent to MD+DI, Abbott wrote, “We already have an Amulet IDE trial underway that is intended to support our submission for approval in the U.S. for Amplatzer Amulet. The newly announced CATALYST trial will support our submission for an expanded indication for Amulet as a safe and effective alternative to NOAC drugs for patients with atrial fibrillation and at risk of stroke.”...
Source: MDDI - February 3, 2020 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Regulatory and Compliance Source Type: news

TAVR Valves Compared, and Other Lessons on the Management of AS TAVR Valves Compared, and Other Lessons on the Management of AS
Walid Amara and Eric Van Belle discuss the latest data from the American Heart Association meeting on transcatheter aortic valve replacement and AS management.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - February 3, 2020 Category: Cardiology Tags: Cardiology Expert Interview Source Type: news

Abbott Has Big Win in TMVI Market
The transcatheter mitral valve implantation (TMVI) market is receiving a huge jolt through a new regulatory approval. Abbott Laboratories said it has obtained CE mark for the Tendyne System. The Abbott Park, IL-based company’s device treats significant mitral regurgitation in patients requiring heart valve replacement who are not candidates for open-heart surgery or transcatheter mitral valve repair. Tendyne is delivered through a small incision in the chest and up through the heart where it is implanted in a beating heart, replacing the person's native mitral valve. Abbott’s valve is fu...
Source: MDDI - January 30, 2020 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

Abbott's Tendyne(TM) Device Receives World's First CE Mark for Transcatheter Mitral Valve Implantation
First-of-its-kind technology addresses critical need to eliminate mitral regurgitation when surgery or mitral repair is not an option Tendyne valve provides relief from heart failure symptoms and quality-of-life improvement in high-surgical-risk patient... Devices, Interventional, Cardiology, Regulatory Abbott, Tendyne, Transcatheter, Mitral Valve, TMVI (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2020 Category: Pharmaceuticals Source Type: news

NEJM: transcatheter aortic valve replacement shows similar safety outcomes as open-heart surgery
(Cedars-Sinai Medical Center) A new study from the Smidt Heart Institute at Cedars-Sinai and other centers nationwide shows that patients who underwent a minimally invasive transcatheter aortic-valve replacement (TAVR), had similar key 5-year clinical outcomes of death and stroke as patients who had traditional open-heart surgery to replace the valve. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 29, 2020 Category: International Medicine & Public Health Source Type: news

TAVR Increasingly Being Used in Young Adults Despite Uncertainty
TUESDAY, Jan. 28, 2020 -- For young adults undergoing aortic valve replacement (AVR), use of transcatheter AVR (TAVR) has increased even though open heart surgery currently is considered the best option, according to a study presented at the annual... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 28, 2020 Category: Pharmaceuticals Source Type: news

Should We Worry About Bicuspid Aortic Valve?
Discussion The aortic valve usually has 3 leaflets. In bicuspid aortic valve (BAV) there are 2 asymmetric leaflets with a fish-mouthed orifice between them which may not open fully. It occurs in about 0.5-2% of the population making it one of the most common congenital heart anomalies and the most common one in adults. Transmission is autosomal dominant yet males are more likely to have BAV, indicating potential reduced penetrance in females. “BAVs are different, however, in that the tissue pathology is not limited to the valves’ leaflets but extends from the left ventricular outflow tract to the ascending thor...
Source: PediatricEducation.org - January 27, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

ECG Challenge: Cardiac Abnormalities After Aortic Valve Replacement ECG Challenge: Cardiac Abnormalities After Aortic Valve Replacement
At a routine follow-up after an aortic valve replacement, a 56-year-old woman complains of fatigue and chest discomfort. What does her ECG show?Medscape Cardiology (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 21, 2020 Category: Intensive Care Tags: Cardiology Clinical Case Source Type: news

FDA clears patient-specific 3D-printed airway stent
The U.S. Food and Drug Administration (FDA) has cleared patient-specific 3D-printed...Read more on AuntMinnie.comRelated Reading: 3 ways to advance 3D printing in radiology 3D printing helps unravel rare cardiac anomalies 3D printing may improve safety of upper GI surgery Wash. groups partner on 3D printing for heart disease 3D printing technique improves heart valve sizing (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 13, 2020 Category: Radiology Source Type: news

Medtech in a Minute: A Huge Merger Flop, a TAVR Breakthrough, and More
Illumina-PacBio Merger Axed Illumina and PacBio called off a $1.2 billion merger after FTC ran interference, saying the pairing could create a monopoly in the next-generation sequencing market. Illumina will now pay PacBio a termination fee of $98 million.   Breakthrough Device Designation Signals a Promising Year for TAVR FDA granted JenaValve a breakthrough device designation for pericardial transcatheter aortic valve replacement (TAVR) system, signaling another promising year for the space. The designation is for severe aortic regurgitation (AR) and AR-dominant mixed aorti...
Source: MDDI - January 10, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Does JenaValve ’s New Designation Signal the Start of Another Strong Year for TAVR?
JenaValve is showing significant progress in the plan to get its transcatheter aortic valve replacement (TAVR) system approved. FDA granted the Irvine, CA-based company Breakthrough Device Designation for the JenaValve Pericardial TAVR system. This designation is for severe aortic regurgitation (AR) and AR-dominant mixed aortic valve disease, a life-threatening and seriously debilitating condition, in patients at high risk for surgery. The JenaValve Pericardial TAVR System consists of a bioprosthesis comprised of a self-expanding nitinol stent with a porcine pericardial valve manufactured using state-of-the-art tissue proc...
Source: MDDI - January 9, 2020 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Business Source Type: news